The rate of progression varies significantly from person to person. There is not good data on outcomes; it appears that<unk>  likely leads to earlier death, but people with<unk>  can live many years after diagnosis with relatively good quality of life.
Adult polyglucosan body disease
Akureyri disease
Anti-AQP4 disease
GM2-gangliosidosis, AB variant
Familial amyloid neuropathy
Familial amyloid polyneuropathy
Zaki syndrome
Gangliosidosis